Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available?

BMJ. 2020 Aug 24:370:m3260. doi: 10.1136/bmj.m3260.

Authors

Raymond M Johnson¹, Peter Doshi², David Healy³

Affiliations

¹ Yale School of Medicine, New Haven, Connecticut, USA Raymond.Johnson@yale.edu pdoshi@rx.umaryland.edu.
² Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA Raymond.Johnson@yale.edu pdoshi@rx.umaryland.edu.
³ Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.

PMID: 32839164
DOI: 10.1136/bmj.m3260

No abstract available

MeSH terms

Access to Information / ethics*
Antiviral Agents / therapeutic use
Betacoronavirus*
COVID-19
COVID-19 Drug Treatment
COVID-19 Vaccines
Clinical Trials as Topic
Coronavirus Infections / drug therapy
Coronavirus Infections / prevention & control
Coronavirus Infections / therapy*
Evidence-Based Medicine / ethics*
Global Health
Humans
Pandemics
Pneumonia, Viral / therapy*
Practice Patterns, Physicians' / ethics*
SARS-CoV-2
Viral Vaccines*

Substances

Antiviral Agents
COVID-19 Vaccines
Viral Vaccines